INFLUENCE OF ACETYLATOR PHENOTYPE ON OUTCOME OF TREATMENT WITH PHENELZINE, IN A CLINICAL-TRIAL

被引：21

作者：

MARSHALL, EF

MOUNTJOY, CQ

CAMPBELL, IC

GARSIDE, RF

LEITCH, IM

ROTH, M

机构：

来源：

关键词：

D O I：

10.1111/j.1365-2125.1978.tb04593.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：247 / 254

页数：8

共 17 条

CONTRACTOR, SF .

[2]

DUNLEAVY DL, 1973, ARCH GEN PSYCHIAT, V28, P353

[3]

EVANS DAP, 1965, CLIN PHARMACOL THER, V6, P430

[4] VARIANCE AND COVARIANCE ANALYSES FOR UNBALANCED CLASSIFICATIONS [J].

FEDERER, WT .

[5]

GOODMAN L, 1970, PHARMACOLOGICAL BASI

JOHNSTONE, EC .

PSYCHOPHARMACOLOGIA, 1976, 46 (03) :289-294

[7]

JOHNSTONE EC, 1973, LANCET, V1, P567

[8]

MARSHALL EF, 1974, 9 P C C INT NEUR PAR, P757

[9]

MARSHALL EF, 1976, BRIT MED J, V4, P817

[10]

Menon N K, 1968, Bull Int Union Tuberc, V41, P316